Literature DB >> 8869745

The role of thymidylate synthase in cellular regulation.

E Chu1, C J Allegra.   

Abstract

Thymidylate synthase plays a central role in the biosynthesis of thymidylate, an essential precursor for DNA biosynthesis. In addition to its role in catalysis and cellular metabolism, studies from our laboratory have shown that thymidylate synthase functions as an RNA binding protein. Specifically, thymidylate synthase binds with high affinity to its own mRNA resulting in translational repression. An extensive series of experiments have now been performed to elucidate the molecular elements underlying the interaction between thymidylate synthase and its own mRNA. These studies have shed new light into the critical nucleotide sequences and/or secondary structure that are important for protein recognition. As well, studies to define the domains on the protein essential for RNA binding are currently underway. In addition to the characterization of the cis- and trans-acting elements underlying the interaction between thymidylate synthase and its own mRNA, we have recently shown that thymidylate synthase has the capacity to specifically bind in vitro and in vivo to other cellular RNA species. In this regard, thymidylate synthase interacts with the mRNAs of the c-myc onocogene and the p53 tumor suppressor gene. These two genes have been shown to play critical roles in cell cycle control, DNA biosynthesis, and apoptosis. In vitro studies reveal that the interaction of TS with these cell-cycle related mRNAs results in their translational repression. While the biological significance of these cellular RNA/TS protein interactions remains to be defined, these studies suggest a potential role for TS as a mediator in the coordinate regulation of several critical aspects of cellular metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869745     DOI: 10.1016/0065-2571(95)00004-6

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  15 in total

1.  Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.

Authors:  Jeremy E McLean; Nobuko Hamaguchi; Peter Belenky; Sarah E Mortimer; Martin Stanton; Lizbeth Hedstrom
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 2.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines.

Authors:  Stefania Giudice; Luisa Benassi; Giorgia Bertazzoni; Eugenia Veratti; Daria Morini; Paola Azzoni; Maria P Costi; Alberto Venturelli; Silvia Pirondi; Stefania Seidenari; Cristina Magnoni
Journal:  Invest New Drugs       Date:  2011-09-01       Impact factor: 3.850

4.  Specific binding of Hoechst 33258 to site 1 thymidylate synthase mRNA.

Authors:  J Cho; R R Rando
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

5.  Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase.

Authors:  Maria Marjorette O Peña; Yang Yang Xing; Sangita Koli; Franklin G Berger
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

6.  Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.

Authors:  P J Ferguson; J M DeMoor; M D Vincent; J Koropatnick
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

7.  Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells.

Authors:  P J Ferguson; O Collins; N M Dean; J DeMoor; C S Li; M D Vincent; J Koropatnick
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

8.  Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors.

Authors:  Leslie L Lovelace; Lydia M Gibson; Lukasz Lebioda
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

9.  Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.

Authors:  Xiaoxiang Guan; Hongliang Liu; Jingfang Ju; Yangkai Li; Peng Li; Li-E Wang; Abenaa M Brewster; Thomas A Buchholz; Banu K Arun; Qingyi Wei; Zhensheng Liu
Journal:  Mol Carcinog       Date:  2013-10-26       Impact factor: 4.784

10.  Gene expression in cortex and hippocampus during acute pneumococcal meningitis.

Authors:  Roney S Coimbra; Veronique Voisin; Antoine B de Saizieu; Raija L P Lindberg; Matthias Wittwer; David Leppert; Stephen L Leib
Journal:  BMC Biol       Date:  2006-06-02       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.